|
|
| MRD / Regn No. |
: 20260000017 |
Date |
: 09/06/2026 |
| Patient Name |
: Sankaramurugan Devishanmugan |
Age & Gender |
: 38 Yrs. / Male |
| Contact No. |
: 7092587124 |
UHID |
: |
| Ht / Wt / BMI |
: 174 / 84.2 / 27.81 |
BP S / BP D |
: 108 / 81 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
OBESITY (08/Jan/2021) | TYPE 2 DM (08/Jan/2020) | |
|
Subjective |
: |
TYPE 2 DM FOR 5 YEARS,DYSLIPIDEMIA,GB POLYP,DIARRHEA RESOLVED
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,OBESITY |
|
Plan |
: |
INCREASE OZEMPIC TO 1 MG,SEE ME IN 2 MONTHS WITH TESTING |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 98 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.8 % | POST PRANDIAL GLUCOSE (2HPP): 103 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET EMPAGLIFLOZIN
EMPAPRO
Medicine For DIABETES HEART KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
|
| MAY CAUSE GENITOURINARY INFECTION | |
|
2 |
INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 08/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |